乳腺癌中对新辅助化疗的耐药性:一种代谢视角
Manon Desgres1, Melis Poyraz2, Buse Sari2
1Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Avenue Hippocrate 57, B1.57.04, Brussels, B-1200, Belgium. manon.desgres@uclouvain.be.
Journal of experimental & clinical cancer research : CR
|August 12, 2025
概括
乳腺癌 (BC) 中的新辅助化疗 (NAC) 耐药性是一个重大挑战. 本综述探讨了代谢成像和向代谢途径,以改善NAC反应和个性化治疗.
科学领域:
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
- 生物化学 生物化学
背景情况:
- 新辅助化疗 (NAC) 对高风险的早期乳腺癌 (BC) 非常重要.
- 在超过一半的患者中,NAC耐药性导致显著的残留癌症负担 (RCB).
- 对NAC反应的基因组生物标志物有限,阻碍了个性化医疗.
研究的目的:
- 审查代谢成像和代谢学方面的进展,以预测BC的NAC反应.
- 讨论瘤微环境 (TME) 在代谢重编程和抵抗中的作用.
- 探索新的代谢向疗法和临床前模型来克服NAC耐药性.
主要方法:
- 关于新陈代谢成像和新陈代谢学在BC的当前文献的综述.
- 分析瘤微环境对代谢可塑性的影响.
- 探索针对瘤代谢的新兴治疗策略.
主要成果:
- 瘤代谢重编程是NAC耐药性的关键非遗传驱动因素.
- 代谢成像和代谢学在预测NAC反应方面表现有前途.
- 诸如缺氧和酸化等TME因素有助于代谢可塑性和耐药性.
结论:
- 代谢框架对于克服早期BC的NAC耐药性至关重要.
- 向瘤代谢为精确瘤学提供了一个有希望的途径.
- 整合代谢见解可以改善治疗策略和患者的治疗结果.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


